InVitro International, Inc.IVRO

Key ratios

Operating cash flow growth

27.0%2022

EPS growth

6053.9%TTM

2024 6053.9%2023 -93.1%2022 -76.5%

FCF / Sales

12.2%2024

2023 -7.6%2022 3.7%

Net margin

13.2%TTM

2024 13.2%2023 0.2%2022 2.5%

ROA

2.5%2024

2023 -1.0%2022 -4.7%

ROE

7.1%2024

2023 0.1%2022 1.5%

Revenue growth

2.4%2024

2023 -7.1%2022 -14.9%

Track IVRO in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer